![Ronald Ellis](https://d2cax41o7ahm5l.cloudfront.net/cs/ocm/vaccines-immunization-2018-ronald-ellis-1548386887.jpg)
Ronald Ellis
Chief Technology Officer
FutuRx Ltd.
Israel
Biography
Dr. Ellis has over 30 years of line and senior management experience in R&D in large (including Merck), medium & small pharma and biotech companies in US & Israel – directing projects across multiple classes of indications, and directing stages from research and preclinical through development and clinical, plus project management, strategy and evaluation. He was project leader and champion for key phases in the development of five products that accrue ~$4B / year in annual sales, and brought eight product candidates to the clinic. He holds PhD (Cornell U) MBA (U Maryland), and BA (U Chicago) degrees. He has given >125 presentations at international conferences. He is founding and incumbent Editor-in-Chief of the peer-reviewed indexed journal Human Vaccines & Immunotherapeutics.
Research Interest
Immunotherapeutics and Vaccines